Johnson & Johnson

5 members

What's driving coverage of Johnson & Johnson right now?

Corporate ratings

High Risk

Johnson & Johnson was rated High Risk because it has adopted race- and identity-based policies and philanthropic practices that prioritize preferential treatment over merit, along with employment protections seen as favoring identity politics. The company is also viewed as engaging heavily in political advocacy, funding, and governance actions that shift its focus from core business objectives toward partisan and divisive social issues.

CancellationsMedium Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

5 memberscoverage spread: L25/C50/R25

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Business
J&J Wins FDA De Novo OTTAVA System
Johnson & Johnson has received FDA De Novo clearance for its Ottava robotic surgical system, marking its entry into the U.S. market as a table-integrated, space-saving alternative aimed at general soft-tissue procedures. The company plans a selective U.S. rollout and ongoing global expansion, supported by an inguinal hernia trial and continued development of additional indications and regulatory approvals amid competition from Intuitive Surgical's established da Vinci platform.
8 sources

Johnson & Johnson

Corporate ratings

Comments

J&J Wins FDA De Novo OTTAVA System

Johnson & Johnson

Overview

Corporate ratings

Comments

J&J Wins FDA De Novo OTTAVA System

Johnson & Johnson across IJR

Overview

Johnson & Johnson across IJR